Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Presentations

Nicklas Westerholm presenting at ABGSC Life Science Summit

May 18, 2022

Egetis – Corporate Presentation May 2022

May 17, 2022

Peder Walberg presenting at Redeye Orphan Drugs event

April 27, 2022

Handelsbanken Healthy Hour

March 23, 2022

Redeye interview with CEO after Q4 report 17 February 2022

February 17, 2022

Webcast regarding US regulatory path

January 18, 2022

Webcast regarding marketing authorisation application for Emcitate®

December 13, 2021

Redeye life science day

November 11, 2021

Redeye interview with the CEO in connection with the Q3 report

November 4, 2021

Interview with Peder Walberg at Pareto, operative director of the board and founder of Rare Thyroid Therapeutics (in Swedish)

October 28, 2021

Presentation at Penser

30 september, 2021

The Pareto Healthcare conference presentation

September 1, 2021

ABGSC Life Science Summit

May 25

Erik Penser Bank – Commercialization of pharmaceuticals

May 6, 2021

Aktiedagen (in Swedish)

May 4

Redeye Orphan Drugs

April 28, 2021

Interview with Dr Thomas Lönngren, nominated CoB and CEO Nicklas Westerholm

April 1, 2021

Interview with CEO Nicklas Westerholm at Redeye

February 18, 2021

Interview with CEO Nicklas Westerholm in Pareto TV

February 1, 2021

Company investor and analyst presentation – acquisition of RTT

October 5, 2020

Acquisition of Rare Thyroid Therapeutics – Interview at Redeye

October 5, 2020

Egetis and RTT agree to join forces

October 5, 2020

Pareto Healthcare Seminar – Company presentation

September 2, 2020

 

Calendar and upcoming reports

August 19, 2022
Half-year report January - June

November 8, 2022
Interim report January - September

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com